The US investments are increasing in the field of precise medicine, the increasing use by government grants; initiatives of cutting-edge methods and a favorable legal environment are the factors that help to promote regional market growth. The precise medicine industries are at the forefront of North America. Furthermore, the increasing incidence of respiratory and oncological conditions as lifestyles change is the primary cause of market demand. Increased health care expenditure and the presence of key operating players in North America will stimulate the growth of businesses.
The global precision medicine market size is expected to reach around US$ 84 Bn by 2026 and is anticipated to grow at a CAGR of around 10% in terms of revenue during the forecast period 2019 to 2026.
The global precision medicine market, Europe has retained a significant share and is expected to develop at a constant pace during the forecast period. Increasing use of precise diagnostic devices, electronic health records and drugs prescribed for a particular disease also contribute to the market growth. In addition, European companies are focused on mergers and acquisitions that are intended to encourage the industry growth.
The demand for precision medicinal products is anticipated to increase in Asia Pacific with high CAGR as the incidence of cancer increases and the ageing population. Government, private grants and R&D investors are anticipated to increase market development in precise medicine market. In addition, Asia Pacific will speed up the growth of precise medical companies with the presence of a large patient pool together with enhanced R&D investment.
In Latin America, the precise medicine market will be driven by health infrastructure development, population growth and the boom in the technology sector. Factor such as a lack of knowledge about the health of Latin American is expected to curb the precision market growth.
The global precision medicine industry, in Middle East & Africa region has a considerable share. The market is nevertheless anticipated to grow due to large personal investments in the Middle East nations. In addition, the growing prevalence and enhanced public efforts to enhance healthcare contribute to the growth of the economy.
Geographically, Africa has the least share of the global precision medicine market owing to powerful public policies and bad economies. In stable nations like Botswana, Ghana in Africa is gaining momentum with regards to growth, on the other side, the increasing knowledge of the medical industry.
Get Free Report Sample Copy@ https://www.acumenresearchandconsulting.com/request-sample/1588
Key Players & Strategies
Major players include in this report are Major players include in this report are Tepnel Pharma Services, Novartis, Qiagen, Biocrates Life Sciences, NanoString Technologies, Roche, Pfizer, Eagle Genomics, Quest Diagnostics, Menarini Silicon Biosystems, Intomics, and Teva Pharmaceutical and Others.
GE Healthcare extended its Healthcare IT Center of Excellence in Szeged, Hungary, in June 2015 to help with the diagnosis of illnesses that are life-threatening, such as liver cancer and other conditions.
Signature Diagnostics AG, a private company headquartered in Potsdam, Germany, was purchased by Roche in February, 2015.
Click Here to get more report information for your business help: http://www.globenewswire.com/news-release/2019/10/09/1927401/0/en/Precision-Medicine-Market-Size-to-Worth-US-84-Bn-by-2026.html
20+ years of diverse and extensive experience in higher education including teaching, research, and university and community service in overseas universities and colleges.
Associate Editor, and publications in international refereed journals and presented most of them in international conferences in the fields of Applied Multivariate Statistics, Mortality, Social Science, Economics.